Coronary heart disease is a leading cause of death for Australian women, yet women have been less likely than men to receive key heart attack treatment, and are under-represented in the trials that shape care.
Coronary heart disease develops when fatty plaque builds up in the arteries that supply blood to the heart. A heart attack happens when an artery becomes blocked [7]. It is a leading cause of death for Australian women. In 2025 it was the second leading cause after dementia, with 5,965 women dying from it [1].
The gap is not only in who gets heart disease, but in how women are treated when they do. One study looked at nearly 2,900 people treated for a major heart attack at 41 Australian hospitals between 2009 and 2016. Women were about half as likely as men to have a coronary angiogram, a test that shows whether the heart’s arteries are narrowed or blocked. They were also less likely to be given key medicines when they left hospital, or to be referred to cardiac rehabilitation. They were about twice as likely to die within six months. These differences remained after the researchers allowed for how high-risk each patient was on arrival, using a standard score that includes age [2].
Symptoms are part of the story. Chest pain is the most common heart attack symptom in both women and men, but women under 50 more often have symptoms other than chest pain, such as pain in the jaw, shoulder or back, nausea, or breathlessness. The Heart Foundation’s guide to women’s risk factors and warning signs explains them [6].
5,965
Australian women who died from coronary (ischaemic) heart disease in 2025, about 16 a day. It was the second leading cause of death for women, after dementia. Preliminary data.
Women's odds of having a coronary angiogram after a major heart attack, compared with men (odds ratio 0.53), at 41 Australian hospitals. The data covers 2009–2016.
Share of participants who were women in 1,079 cardiovascular trials, 2017–2023. Women were most under-represented, relative to how common the disease is in women, in coronary heart disease, stroke and acute coronary syndrome trials.
Women who had never seen their doctor for a general heart health check. From the Her Heart 2023 National Report Card survey, as reported by the Heart Foundation.
The best-known Australian evidence on unequal heart attack care is now dated: it covers patients treated up to 2016. Newer data is more mixed. A 2024 study looked at 2,747 people in Queensland who had emergency stenting, a procedure to open a blocked heart artery, between 2017 and 2020. Women still waited longer for treatment, and fewer were treated within the 90-minute target (50% compared with 58%). After allowing for other factors, being a woman was not linked to a higher risk of dying within 30 days, or of dying from heart disease within a year [5]. Faster, more consistent care may be narrowing the gap, but delays remain, and there is no recent national picture.
Many women have never had their heart health checked. In a 2023 survey, more than half said they had never seen their doctor for a general heart health check [4]. A Medicare-funded Heart Health Check with a GP is available to people aged 45 and over, or 30 and over for First Nations people.
Global context
Women remain under-represented in the research that shapes heart care. Across 1,079 cardiovascular trials registered between 2017 and 2023, women made up 41% of participants. Compared with how common each condition is in women, they were least well represented in trials for coronary heart disease, stroke and acute coronary syndrome [3].
In numbers
From the In numbers page. Each chart lists its own source.
Australia2025
5,965
Coronary heart disease killed 5,965 Australian women in 2025. Breast cancer killed 3,244.
About 16 women a day died from coronary heart disease, and about 9 a day from breast cancer. Each figure stands for 100 deaths, rounded to the nearest 100.Show the data
Australian women, deaths registered in 2025
Cause (ABS name)
Deaths
Deaths a day
Years of potential life lost
Ischaemic heart diseases (I20-I25)
5,965
16.3
13,959
Malignant neoplasm of breast (C50)
3,244
8.9
25,503
Deaths a day = deaths ÷ 365.
Breast cancer kills women younger, so it costs more years of life: 25,503 years of potential life lost, compared with 13,959 for coronary heart disease.
Women are 35% of heart disease trial participants but carry 39% of the burden.
Half of heart disease trials are less than 28.5% women.
Women's share of trial participants was below their share of the disease burden in 5 of 9 conditions. The biggest shortfall was in Alzheimer's and other dementias (58% of participants, 66% of the burden).Show the data
Women's share of trial participants and of the disease burden, by condition (sorted by the gap)
Condition
Trials
Women, all participants
Women, median trial
Women, share of burden
Alzheimer's and other dementias
862
58.4%
55.6%
65.6%
Low back pain
230
56.5%
55.4%
62.5%
Anxiety disorders
600
55.6%
63.0%
60.9%
Ischaemic heart disease
684
34.9%
28.5%
38.8%
Stroke
636
42.3%
40.0%
45.2%
Osteoarthritis
549
61.7%
60.1%
61.0%
Depressive disorders
1,277
63.2%
65.1%
60.4%
Rheumatoid arthritis
450
79.4%
80.1%
72.1%
Migraine
290
83.9%
83.9%
68.9%
Some trials are counted under more than one condition: 5,578 trial–condition entries, 5,198 distinct trials. Very large trials can skew the "all participants" share; the median trial is shown too.
Our analysis of 5,198 ClinicalTrials.gov trials (2010–2025) that reported participants by sex, compared with GBD 2023 burden (DALYs). Studies that compare with prevalence find similar patterns (Rivera et al., JAMA Netw Open 2025).